Monarch Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MONARCH PHARMS, and what generic and branded alternatives to MONARCH PHARMS drugs are available?
MONARCH PHARMS has twenty-two approved drugs.
Drugs and US Patents for Monarch Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monarch Pharms | QUIBRON-T/SR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087563-001 | Jun 21, 1983 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Monarch Pharms | SEPTRA GRAPE | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017598-002 | Feb 12, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Monarch Pharms | SEPTRA | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 018452-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Monarch Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Monarch Pharms | QUIBRON-T/SR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087563-001 | Jun 21, 1983 | 4,465,660 | ⤷ Subscribe |
Monarch Pharms | SEPTRA DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017376-002 | Approved Prior to Jan 1, 1982 | 4,209,513 | ⤷ Subscribe |
Monarch Pharms | SEPTRA | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017376-001 | Approved Prior to Jan 1, 1982 | 4,209,513 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.